Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profiling-Reference-Cited by-同舟云学术

Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profiling

Published:2017-03-20 Issue:4 Volume:6 Page:e1305535
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Siska Peter J.¹²,Johnpulle Romany A. N.³,Zhou Alice⁴,Bordeaux Jennifer⁵,Kim Ju Young⁵,Dabbas Bashar⁶,Dakappagari Naveen⁵,Rathmell Jeffrey C.¹⁷,Rathmell W. Kimryn³,Morgans Alicia K.³,Balko Justin M.³⁷,Johnson Douglas B.³

Affiliation:

1. Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany

2. Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center, Nashville, TN, USA

3. Department of Medicine, Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center, Nashville, TN, USA

4. School of Medicine, Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center, Nashville, TN, USA

5. Navigate BioPharma Services, Inc., a Novartis Company, Carlsbad, CA, USA

6. Genoptix, Inc., Carlsbad, CA, USA

7. Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, USA

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1305535

Reference33 articles.